259 related articles for article (PubMed ID: 10225968)
1. Endogenous IL-1alpha from systemic sclerosis fibroblasts induces IL-6 and PDGF-A.
Kawaguchi Y; Hara M; Wright TM
J Clin Invest; 1999 May; 103(9):1253-60. PubMed ID: 10225968
[TBL] [Abstract][Full Text] [Related]
2. Autocrine activation by interleukin 1alpha induces the fibrogenic phenotype of systemic sclerosis fibroblasts.
Kawaguchi Y; McCarthy SA; Watkins SC; Wright TM
J Rheumatol; 2004 Oct; 31(10):1946-54. PubMed ID: 15468358
[TBL] [Abstract][Full Text] [Related]
3. Enhanced interleukin 6 production by cultured fibroblasts from patients with systemic sclerosis in response to platelet derived growth factor.
Takemura H; Suzuki H; Fujisawa H; Yuhara T; Akama T; Yamane K; Kashiwagi H
J Rheumatol; 1998 Aug; 25(8):1534-9. PubMed ID: 9712097
[TBL] [Abstract][Full Text] [Related]
4. Expression of hepatocyte growth factor and its receptor (c-met) in skin fibroblasts from patients with systemic sclerosis.
Kawaguchi Y; Harigai M; Hara M; Fukasawa C; Takagi K; Tanaka M; Tanaka E; Nishimagi E; Kamatani N
J Rheumatol; 2002 Sep; 29(9):1877-83. PubMed ID: 12233882
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis.
Distler O; Pap T; Kowal-Bielecka O; Meyringer R; Guiducci S; Landthaler M; Schölmerich J; Michel BA; Gay RE; Matucci-Cerinic M; Gay S; Müller-Ladner U
Arthritis Rheum; 2001 Nov; 44(11):2665-78. PubMed ID: 11710722
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway.
Sambo P; Baroni SS; Luchetti M; Paroncini P; Dusi S; Orlandini G; Gabrielli A
Arthritis Rheum; 2001 Nov; 44(11):2653-64. PubMed ID: 11710721
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 1 receptor on fibroblasts from systemic sclerosis patients induces excessive functional responses to interleukin 1 beta.
Kawaguchi Y; Harigai M; Suzuki K; Hara M; Kobayashi K; Ishizuka T; Matsuki Y; Tanaka N; Nakamura H
Biochem Biophys Res Commun; 1993 Jan; 190(1):154-61. PubMed ID: 8422241
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis.
Maurer B; Stanczyk J; Jüngel A; Akhmetshina A; Trenkmann M; Brock M; Kowal-Bielecka O; Gay RE; Michel BA; Distler JH; Gay S; Distler O
Arthritis Rheum; 2010 Jun; 62(6):1733-43. PubMed ID: 20201077
[TBL] [Abstract][Full Text] [Related]
9. Intracellular IL-1alpha-binding proteins contribute to biological functions of endogenous IL-1alpha in systemic sclerosis fibroblasts.
Kawaguchi Y; Nishimagi E; Tochimoto A; Kawamoto M; Katsumata Y; Soejima M; Kanno T; Kamatani N; Hara M
Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14501-6. PubMed ID: 16971486
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of heat-shock protein 47 is associated with overproduction of type I procollagen in systemic sclerosis skin fibroblasts.
Kuroda K; Tsukifuji R; Shinkai H
J Invest Dermatol; 1998 Dec; 111(6):1023-8. PubMed ID: 9856811
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis.
Chizzolini C; Raschi E; Rezzonico R; Testoni C; Mallone R; Gabrielli A; Facchini A; Del Papa N; Borghi MO; Dayer JM; Meroni PL
Arthritis Rheum; 2002 Jun; 46(6):1602-13. PubMed ID: 12115192
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
[TBL] [Abstract][Full Text] [Related]
13. IL-1 alpha gene expression and protein production by fibroblasts from patients with systemic sclerosis.
Kawaguchi Y
Clin Exp Immunol; 1994 Sep; 97(3):445-50. PubMed ID: 8082299
[TBL] [Abstract][Full Text] [Related]
14. Blockade of PDGF Receptors by Crenolanib Has Therapeutic Effect in Patient Fibroblasts and in Preclinical Models of Systemic Sclerosis.
Makino K; Makino T; Stawski L; Mantero JC; Lafyatis R; Simms R; Trojanowska M
J Invest Dermatol; 2017 Aug; 137(8):1671-1681. PubMed ID: 28433542
[TBL] [Abstract][Full Text] [Related]
15. Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts.
Nakashima T; Jinnin M; Yamane K; Honda N; Kajihara I; Makino T; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
J Immunol; 2012 Apr; 188(8):3573-83. PubMed ID: 22403442
[TBL] [Abstract][Full Text] [Related]
16. Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis.
Distler JH; Jüngel A; Kowal-Bielecka O; Michel BA; Gay RE; Sprott H; Matucci-Cerinic M; Chilla M; Reich K; Kalden JR; Müller-Ladner U; Lorenz HM; Gay S; Distler O
Arthritis Rheum; 2005 Mar; 52(3):856-64. PubMed ID: 15751077
[TBL] [Abstract][Full Text] [Related]
17. A reactive oxygen species-mediated loop maintains increased expression of NADPH oxidases 2 and 4 in skin fibroblasts from patients with systemic sclerosis.
Spadoni T; Svegliati Baroni S; Amico D; Albani L; Moroncini G; Avvedimento EV; Gabrielli A
Arthritis Rheumatol; 2015 Jun; 67(6):1611-22. PubMed ID: 25707572
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 1alpha single-nucleotide polymorphism associated with systemic sclerosis.
Hutyrová B; Lukác J; Bosák V; Buc M; du Bois R; Petrek M
J Rheumatol; 2004 Jan; 31(1):81-4. PubMed ID: 14705223
[TBL] [Abstract][Full Text] [Related]
19. Expression of platelet-derived growth factor B-chain and platelet-derived growth factor beta-receptor in fibroblasts of scleroderma.
Zheng XY; Zhang JZ; Tu P; Ma SQ
J Dermatol Sci; 1998 Nov; 18(2):90-7. PubMed ID: 9833975
[TBL] [Abstract][Full Text] [Related]
20. [Role of PDGF-A/PDGFR-α in proliferation and transdifferentiation of fibroblasts from skin lesions of patients with systemic sclerosis].
Liu T; Zhang J
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Apr; 32(4):496-501. PubMed ID: 22543129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
